Literature DB >> 19198625

15-LOX-1 transcription suppression through the NuRD complex in colon cancer cells.

X Zuo1, J S Morris, R Broaddus, I Shureiqi.   

Abstract

15-Lipoxygenase-1 (15-LOX-1) is transcriptionally silenced in cancer cells, and its transcription reactivation (for example, through histone deacetylase inhibitors (HDACIs)) restores apoptosis to cancer cells. However, the exact mechanism underlying 15-LOX-1 transcription reactivation in cancer cells is still undefined. Therefore, we evaluated the critical mechanisms required for 15-LOX-1 transcription reactivation in colon cancer cells. Specific HDAC1 and HDAC2 inhibition activated 15-LOX-1 transcription. 15-LOX-1 transcription was repressed through transcription repressor complex recruitment in the region of -120 to -391 of the 15-LOX-1 promoter. The nucleosome remodeling and histone deacetylase (NuRD) repression complex was recruited to this region. Depsipeptide significantly reduced the recruitment of NuRD key components (for example, metastasis-associated protein 1 (MTA1) and HDAC1) to the 15-LOX-1 promoter before 15-LOX-1 transcriptional activation. Knock down of NuRD key components (for example, MTA1 and HDAC1) by small interfering RNA (siRNA) activated 15-LOX-1 transcription, as measured by luciferase reporter assays in stably transfected SW480 cells with the 15-LOX-1 promoter construct of the -391, but not the -120 region. Relative to expression in normal tissue, MTA1 expression in colorectal cancer mucosa from colorectal cancer patients was negatively related to 15-LOX-1 expression. Thus, our results show that NuRD contributes to 15-LOX-1 transcription suppression in colon cancer cells and that HDACIs can inhibit NuRD recruitment to a promoter to activate gene transcription, as in the case of 15-LOX-1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19198625      PMCID: PMC2743348          DOI: 10.1038/onc.2008.494

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  49 in total

1.  Regulation of human 12/15-lipoxygenase by Stat6-dependent transcription.

Authors:  D J Conrad; M Lu
Journal:  Am J Respir Cell Mol Biol       Date:  2000-02       Impact factor: 6.914

2.  15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.

Authors:  I Shureiqi; D Chen; R Lotan; P Yang; R A Newman; S M Fischer; S M Lippman
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

3.  Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression.

Authors:  I Shureiqi; X Xu; D Chen; R Lotan; J S Morris; S M Fischer; S M Lippman
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

4.  15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells.

Authors:  I Shureiqi; D Chen; J J Lee; P Yang; R A Newman; D E Brenner; R Lotan; S M Fischer; S M Lippman
Journal:  J Natl Cancer Inst       Date:  2000-07-19       Impact factor: 13.506

5.  Acetylation by histone acetyltransferase CREB-binding protein/p300 of STAT6 is required for transcriptional activation of the 15-lipoxygenase-1 gene.

Authors:  P Shankaranarayanan; P Chaitidis; H Kühn; S Nigam
Journal:  J Biol Chem       Date:  2001-08-16       Impact factor: 5.157

6.  GATA-6 transcriptional regulation of 15-lipoxygenase-1 during NSAID-induced apoptosis in colorectal cancer cells.

Authors:  Imad Shureiqi; Wei Jiang; Susan M Fischer; Xiaochun Xu; Dongning Chen; J Jack Lee; Reuben Lotan; Scott M Lippman
Journal:  Cancer Res       Date:  2002-02-15       Impact factor: 12.701

Review 7.  Mechanism-based target identification and drug discovery in cancer research.

Authors:  J B Gibbs
Journal:  Science       Date:  2000-03-17       Impact factor: 47.728

8.  Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3.

Authors:  J Li; J Wang; J Wang; Z Nawaz; J M Liu; J Qin; J Wong
Journal:  EMBO J       Date:  2000-08-15       Impact factor: 11.598

9.  15-Lipoxygenase-1 transcriptional silencing by DNA methyltransferase-1 independently of DNA methylation.

Authors:  Xiangsheng Zuo; Lanlan Shen; Jean-Pierre Issa; Ofir Moy; Jeffrey S Morris; Scott M Lippman; Imad Shureiqi
Journal:  FASEB J       Date:  2008-01-15       Impact factor: 5.191

10.  Expression of 15-lipoxygenase-1 is regulated by histone acetylation in human colorectal carcinoma.

Authors:  H Kamitani; S Taniura; H Ikawa; T Watanabe; U P Kelavkar; T E Eling
Journal:  Carcinogenesis       Date:  2001-01       Impact factor: 4.944

View more
  13 in total

Review 1.  15-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in?

Authors:  Sun Il Lee; Xiangsheng Zuo; Imad Shureiqi
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

Review 2.  ALOX15 as a suppressor of inflammation and cancer: Lost in the link.

Authors:  Rui Tian; Xiangsheng Zuo; Jonathan Jaoude; Fei Mao; Jennifer Colby; Imad Shureiqi
Journal:  Prostaglandins Other Lipid Mediat       Date:  2017-01-13       Impact factor: 3.072

Review 3.  Emerging cellular functions of the lipid metabolizing enzyme 15-Lipoxygenase-1.

Authors:  Melis Çolakoğlu; Sinem Tunçer; Sreeparna Banerjee
Journal:  Cell Prolif       Date:  2018-07-30       Impact factor: 6.831

4.  Interplay between 15-lipoxygenase-1 and metastasis-associated antigen 1 in the metastatic potential of colorectal cancer.

Authors:  S Tunçer; S Tunçay Çağatay; A G Keşküş; M Çolakoğlu; Ö Konu; S Banerjee
Journal:  Cell Prolif       Date:  2016-06-19       Impact factor: 6.831

5.  Induction of apoptosis by Trichostatin A in human breast cancer cell lines: involvement of 15-Lox-1.

Authors:  Masoumeh Tavakoli-Yaraki; Fatemeh Karami-Tehrani; Vahid Salimi; Majid Sirati-Sabet
Journal:  Tumour Biol       Date:  2012-10-06

6.  Ras responsive element binding protein-1 (RREB-1) down-regulates hZIP1 expression in prostate cancer cells.

Authors:  Beatrice C Milon; Anthony Agyapong; Roderick Bautista; Leslie C Costello; Renty B Franklin
Journal:  Prostate       Date:  2010-02-15       Impact factor: 4.104

Review 7.  Eicosanoid pathway in colorectal cancer: Recent updates.

Authors:  Sinem Tuncer; Sreeparna Banerjee
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

8.  Characterization of a human 12/15-lipoxygenase promoter variant associated with atherosclerosis identifies vimentin as a promoter binding protein.

Authors:  Susmita Samanta; Kurtis Anderson; Sean Moran; David Hawke; David Gorenstein; Myriam Fornage
Journal:  PLoS One       Date:  2012-08-07       Impact factor: 3.240

Review 9.  The role of lipoxygenases in pathophysiology; new insights and future perspectives.

Authors:  Ryuichi Mashima; Torayuki Okuyama
Journal:  Redox Biol       Date:  2015-08-07       Impact factor: 11.799

Review 10.  Targeting Lipid Peroxidation for Cancer Treatment.

Authors:  Sofia M Clemente; Oscar H Martínez-Costa; Maria Monsalve; Alejandro K Samhan-Arias
Journal:  Molecules       Date:  2020-11-05       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.